Advances in our understanding of BAFF and APRIL biology are reshaping the treatment landscape for IgA nephropathy (IgAN), with dual pathway inhibition emerging as a promising disease-modifying strateg...

To understand the pathogenesis of IgA nephropathy (IgAN), it’s important to look at the immune processes driving damage caused by the disease. The 4-hit process shows why and how IgAN progresses on th...